REG - OptiBiotix Health - Result of AGM <Origin Href="QuoteRef">OPTIO.L</Origin>
RNS Number : 2161IOptiBiotix Health PLC15 June 201715 June 2017
OptiBiotix Health plc
("OptiBiotix"orthe Company")
Result of AGM
OptiBiotixHealthplc(AIM:OPTI),alifesciencesbusinessdevelopingcompoundstotackleobesity,highcholesterol,
diabetes and skin care,announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
OptiBiotix Health plc
Stephen O'Hara, Chief Executive
Contact via Walbrook below
Cairn Financial Advisers LLP (NOMAD)
Tel: 020 7213 0880
Liam Murray / Jo Turner
finnCap (Broker)
Tel: 020 7220 0500
Adrian Hargrave / Scott Mathieson / Kate Bannatyne (Corporate Finance)
Tony Quirke (Corporate Broking)
Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
About OptiBiotix - www.optibiotix.com
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.
This information is provided by RNSThe company news service from the London Stock ExchangeENDRAGFAMBTMBTBBPR
Recent news on OptiBiotix Health
See all newsREG - OptiBiotix Health - Trading Update
AnnouncementREG - OptiBiotix Health - WellBiome® clinical trial on surgical outcomes
AnnouncementREG - OptiBiotix Health - Statement: SkinBioTherapeutics Announcement
AnnouncementREG - OptiBiotix Health - Large Order and Record Early Orders for 2026
AnnouncementRCS - OptiBiotix Health - New Investor Website
Announcement